Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Gains from Sales and Divestitures (2021 - 2024)

Ryan Specialty Holdings (RYAN) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $627302.0 as the latest value for Q2 2024.

  • On a quarterly basis, Gains from Sales and Divestitures rose 1427.62% to $627302.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $627302.0, a 1427.62% increase, with the full-year FY2023 number at $119999.0, down 95.21% from a year prior.
  • Gains from Sales and Divestitures was $627302.0 for Q2 2024 at Ryan Specialty Holdings, up from $5144.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $2.5 million in Q4 2022 to a low of $5144.0 in Q1 2024.
  • A 4-year average of $531545.1 and a median of $140579.0 in 2022 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 25900.86% in 2022, then plummeted 95.61% in 2023.
  • Ryan Specialty Holdings' Gains from Sales and Divestitures stood at $9634.0 in 2021, then surged by 25900.86% to $2.5 million in 2022, then plummeted by 95.21% to $119999.0 in 2023, then surged by 422.76% to $627302.0 in 2024.
  • Per Business Quant, the three most recent readings for RYAN's Gains from Sales and Divestitures are $627302.0 (Q2 2024), $5144.0 (Q1 2024), and $119999.0 (Q4 2023).